=
Note: Conversion is based on the latest values and formulas.
BioNTech to Present Clinical and Preclinical Data Across mRNA … 24 Apr 2025 · Highlights of BioNTech’s oncology programs to be presented at AACR 2025: BioNTech will present preclinical data characterizing the mode of action of BNT327. BNT327 …
Updates in Therapeutic Development: Clinical Trial Readouts to … 29 Jan 2025 · Explore some of the most highly anticipated clinical trials with data readouts expected in the second half of 2025—key updates that researchers and clinicians in neurology …
Most Anticipated Phase 3 Clinical Trials Completing in July 2025 27 Jun 2025 · These nine clinical trials are anticipated to complete in July 2025. They range in topics from cancer treatments to migraine relief.
AAD 2025 Phase 3 Recap: 7 Trials to Know - hcplive.com 17 Mar 2025 · Phase 2/3 LIBERTY-BP ADEPT trial results presented at AAD 2025 showed that dupilumab (Dupixent) significantly improved disease activity and reduced burden in patients …
Clinical trends for 2025: A year of change | pharmaphorum 4 days ago · Explore the clinical trends expected for 2025 - including ADCs, Radiopharmaceuticals, CGTs, AAV, and rare diseases. Stay ahead of the curve with these …
FDA Drug Approval Decisions Expected in July 2025 16 Jun 2025 · Findings showed an ORR of 31.4%, with 12.2% of patients achieving complete response. Median DOR was longer than 24 months. A phase 3 trial, IGNYTE-3 …
Novartis’s post-Pluvicto plan materialises | ApexOnco - Clinical … 21 Jan 2025 · The upcoming phase 2/3 PSMAction trial, slated to start in April, will enrol PSMA-positive patients who have already received androgen receptor-directed therapy and taxane …
Momentum builds for long-acting HIV solutions as IAS 2025 … 14 Jul 2025 · "The results of the Phase 2 study of MK-8527 shared at IAS 2025 demonstrate a favourable safety and tolerability profile with pharmacokinetic data supporting once-monthly …
Phase III Clinical Trials - BioSpace 15 Jul 2025 · Neurocrine Biosciences Presented One-Year Data from Phase 3 CAHtalyst™ Studies Showing Improvements in Weight-Related Effects of Glucocorticoid Treatment at the …
FDA new drug approvals in Q2 2025 - Nature 15 Jul 2025 · The second quarter of 2025 picked up where the first quarter left off with a somewhat muted novel drug approval landscape. Q1’s total of seven novel drug approvals was …